491 related articles for article (PubMed ID: 18272138)
1. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential.
Japp AG; Newby DE
Biochem Pharmacol; 2008 May; 75(10):1882-92. PubMed ID: 18272138
[TBL] [Abstract][Full Text] [Related]
2. Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target.
Falcão-Pires I; Leite-Moreira AF
Rev Port Cardiol; 2005 Oct; 24(10):1263-76. PubMed ID: 16398242
[TBL] [Abstract][Full Text] [Related]
3. Effects of olmesartan on Apelin/APJ and Akt/endothelial nitric oxide synthase pathway in Dahl rats with end-stage heart failure.
Fukushima H; Kobayashi N; Takeshima H; Koguchi W; Ishimitsu T
J Cardiovasc Pharmacol; 2010 Jan; 55(1):83-8. PubMed ID: 19904215
[TBL] [Abstract][Full Text] [Related]
4. Vascular effects of apelin in vivo in man.
Japp AG; Cruden NL; Amer DA; Li VK; Goudie EB; Johnston NR; Sharma S; Neilson I; Webb DJ; Megson IL; Flapan AD; Newby DE
J Am Coll Cardiol; 2008 Sep; 52(11):908-13. PubMed ID: 18772060
[TBL] [Abstract][Full Text] [Related]
5. Apelin in acute myocardial infarction and heart failure induced by ischemia.
Tycinska AM; Lisowska A; Musial WJ; Sobkowicz B
Clin Chim Acta; 2012 Feb; 413(3-4):406-10. PubMed ID: 22146598
[TBL] [Abstract][Full Text] [Related]
6. Apelin and its receptor APJ in cardiovascular diseases.
Yu XH; Tang ZB; Liu LJ; Qian H; Tang SL; Zhang DW; Tian GP; Tang CK
Clin Chim Acta; 2014 Jan; 428():1-8. PubMed ID: 24055369
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells.
Kleinz MJ; Skepper JN; Davenport AP
Regul Pept; 2005 Mar; 126(3):233-40. PubMed ID: 15664671
[TBL] [Abstract][Full Text] [Related]
8. Apelin suppresses apoptosis of human vascular smooth muscle cells via APJ/PI3-K/Akt signaling pathways.
Cui RR; Mao DA; Yi L; Wang C; Zhang XX; Xie H; Wu XP; Liao XB; Zhou H; Meng JC; Yuan LQ; Liao EY
Amino Acids; 2010 Nov; 39(5):1193-200. PubMed ID: 20495838
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor, APJ.
Fan X; Zhou N; Zhang X; Mukhtar M; Lu Z; Fang J; DuBois GC; Pomerantz RJ
Biochemistry; 2003 Sep; 42(34):10163-8. PubMed ID: 12939143
[TBL] [Abstract][Full Text] [Related]
10. G protein-coupled APJ receptor signaling induces focal adhesion formation and cell motility.
Hashimoto Y; Ishida J; Yamamoto R; Fujiwara K; Asada S; Kasuya Y; Mochizuki N; Fukamizu A
Int J Mol Med; 2005 Nov; 16(5):787-92. PubMed ID: 16211245
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure.
Chong KS; Gardner RS; Morton JJ; Ashley EA; McDonagh TA
Eur J Heart Fail; 2006 Jun; 8(4):355-60. PubMed ID: 16464638
[TBL] [Abstract][Full Text] [Related]
12. Apelin receptor expression in ischemic and non- ischemic kidneys and cardiovascular responses to apelin in chronic two-kidney-one-clip hypertension in rats.
Najafipour H; Soltani Hekmat A; Nekooian AA; Esmaeili-Mahani S
Regul Pept; 2012 Oct; 178(1-3):43-50. PubMed ID: 22796316
[TBL] [Abstract][Full Text] [Related]
13. Apelin protects myocardial injury induced by isoproterenol in rats.
Jia YX; Pan CS; Zhang J; Geng B; Zhao J; Gerns H; Yang J; Chang JK; Tang CS; Qi YF
Regul Pept; 2006 Jan; 133(1-3):147-54. PubMed ID: 16278022
[TBL] [Abstract][Full Text] [Related]
14. Cloning and activation of the bullfrog apelin receptor: Gi/o coupling and high affinity for [Pro1]apelin-13.
Moon MJ; Oh DY; Moon JS; Kim DK; Hwang JI; Lee JY; Kim JI; Cho S; Kwon HB; Seong JY
Mol Cell Endocrinol; 2007 Oct; 277(1-2):51-60. PubMed ID: 17825479
[TBL] [Abstract][Full Text] [Related]
15. In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure.
Sheikh AY; Chun HJ; Glassford AJ; Kundu RK; Kutschka I; Ardigo D; Hendry SL; Wagner RA; Chen MM; Ali ZA; Yue P; Huynh DT; Connolly AJ; Pelletier MP; Tsao PS; Robbins RC; Quertermous T
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H88-98. PubMed ID: 17906101
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the apelin receptor APJ in Fas-induced liver injury.
Yasuzaki H; Yoshida S; Hashimoto T; Shibata W; Inamori M; Toya Y; Tamura K; Maeda S; Umemura S
Liver Int; 2013 Jan; 33(1):118-26. PubMed ID: 23121371
[TBL] [Abstract][Full Text] [Related]
17. Expression and localization of apelin and its receptor APJ in the bovine corpus luteum during the estrous cycle and prostaglandin F2alpha-induced luteolysis.
Shirasuna K; Shimizu T; Sayama K; Asahi T; Sasaki M; Berisha B; Schams D; Miyamoto A
Reproduction; 2008 Apr; 135(4):519-25. PubMed ID: 18367512
[TBL] [Abstract][Full Text] [Related]
18. The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis.
O'Carroll AM; Lolait SJ; Harris LE; Pope GR
J Endocrinol; 2013 Oct; 219(1):R13-35. PubMed ID: 23943882
[TBL] [Abstract][Full Text] [Related]
19. Apelin and APJ, a novel critical factor and therapeutic target for atherosclerosis.
Lv D; Li H; Chen L
Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):527-33. PubMed ID: 23588025
[TBL] [Abstract][Full Text] [Related]
20. Translational promise of the apelin--APJ system.
Barnes G; Japp AG; Newby DE
Heart; 2010 Jul; 96(13):1011-6. PubMed ID: 20584856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
